From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
I mean that seriously because its never been the case that so many people are talking about the impact that they can have on weight loss, diabetes, insulin resistance, and appetite suppression
Some of these conditions have been clearly linked to MTHFR polymorphisms, while others require further research
Lipotropic injections may also help maintain healthy liver function and protect from disease
But indulgence remains important even if brands are encouraged to position indulgent snacks as permissible by offering healthier alternatives
